Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Regeneron Pharmaceuticals, Inc. > Profile

Instuitional Investor - Regeneron Pharmaceuticals, Inc.

Fund Profile
Filing Period:
Fund Name: Regeneron Pharmaceuticals, Inc.
Portfolio Value $1,234,240,208
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Alnylam Pharmaceuticals Inc.
 ALNY 4,444,445 $1,200,089,039 97.23%
2.
Intellia Therapeutics Inc.
 NTLA 3,702,995 $26,328,294 2.13%
3.
2Seventy Bio Inc.
 TSVT 1,254,827 $6,198,845 0.5%
4.
Adverum Biotechnologies Inc.
 ADVM 180,909 $790,572 0.06%
5.
Adicet Bio Inc.
 968,183 $730,978 0.06%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)